Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.

Prenatal glucocorticoids and long-term programming

Seckl · 2004 · European Journal of Endocrinology

Abstract

Epidemiological evidence suggests that low birth weight is associated with an increased risk of cardiovascular, metabolic and neuroendocrine disorders in adult life. Glucocorticoid administration during pregnancy reduces offspring birth weight and alters the maturation of the lung and other organs. We hypothesised that prenatal exposure to excess glucocorticoids or stress might represent a mechanism linking foetal growth with adult pathophysiology. In rats, birth weight is reduced following prenatal exposure to the synthetic steroid dexamethasone, which readily crosses the placenta, or to carbenoxolone, which inhibits 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2), the physiological feto-placental 'barrier' to maternal glucocorticoids. As adults, the offspring exhibit permanent hypertension, hyperglycaemic, increased hypothalamic-pituitary-adrenal (HPA) axis activity and behaviour reminiscent of anxiety. Physiological variations in placental 11beta-HSD2 activity correlate directly with foetal weight. In humans, 11beta-HSD2 gene mutations cause low birth weight. Moreover, low-birth-weight babies have higher plasma cortisol levels throughout adult life, indicating HPA axis programming. The molecular mechanisms may reflect permanent changes in the expression of specific transcription factors, key among which is the glucocorticoid receptor (GR) itself. The differential programming of the GR in different tissues reflects effects upon one or more of the multiple tissue-specific alternate first exons/promoters of the GR gene. Overall, the data suggest that both pharmacological and physiological exposure prenatally to excess glucocorticoids programmes cardiovascular, metabolic and neuroendocrine disorders in adult life.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje.0.151u049

Cites

184 of 184 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 184 references

Cited by

See all 825

Metadata

Authors
Seckl
Venue
European Journal of Endocrinology
Published
2004-11-01
Volume
151
Issue
Suppl_3
Pages
U49-U62
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2157655909
Cited by
825
References
184
Citations by year
2026: 13 · 2025: 13 · 2024: 15 · 2023: 34 · 2022: 22 · 2021: 29 · 2020: 22 · 2019: 35 · 2018: 32 · 2017: 40 · 2016: 44 · 2015: 40 · 2014: 44 · 2013: 67 · 2012: 60
FWCI
30.30
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust
  • British Heart Foundation
  • European Commission
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
antenatal glucocorticoids, low birth weight, developmental programming, dexamethasone, carbenoxolone, 11β-hydroxysteroid dehydrogenase type 2, hypertension, hyperglycemia, hypothalamic-pituitary-adrenal axis, anxiety-like behavior, glucocorticoid receptor, fetal growth, neuroendocrine disorders
MeSH terms
Animals, Animals, Newborn, Behavior, Diabetes Mellitus, Type 1, Female, Glucocorticoids, Humans, Hydrocortisone, Hypertension, Infant, Low Birth Weight, Infant, Newborn, Lung, Pregnancy, Prenatal Exposure Delayed Effects, Stress, Physiological, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prenatal glucocorticoids and long-term programming. https://app.cochat.ai/papers/10.1530/eje.0.151u049
The paper
Seckl. (2004). Prenatal glucocorticoids and long-term programming. European Journal of Endocrinology. https://doi.org/10.1530/eje.0.151u049

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.